metformin and s-adenosylmethionine

metformin has been researched along with s-adenosylmethionine in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's3 (60.00)24.3611
2020's2 (40.00)2.80

Authors

AuthorsStudies
Cacciapuoti, F1
Noureddin, M; Rinella, ME1
Blanco-González, E; Cuyàs, E; Fernández-Arroyo, S; García, RÁ; Joven, J; Menendez, JA; Montes-Bayón, M; Neuzil, J; Stursa, J; Verdura, S; Viollet, B; Werner, L1
Al-Dhabi, NA; Arasu, MV; Arockiaraj, J; C, M; Chatterjee, S; Choi, KC; Karuppiah, K; Natarajan, S; Raj, V; Ramanujam, GM; Ramasamy, M1
Jiang, N; Kong, Q; Li, S; Liu, F; Wang, H; Xiao, Y; Yu, C; Yun, L; Zhu, X1

Reviews

1 review(s) available for metformin and s-adenosylmethionine

ArticleYear
Nonalcoholic Fatty liver disease, diabetes, obesity, and hepatocellular carcinoma.
    Clinics in liver disease, 2015, Volume: 19, Issue:2

    Topics: Carcinoma, Hepatocellular; Chemoprevention; Diabetes Mellitus, Type 2; Endoplasmic Reticulum Stress; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypoglycemic Agents; Incidence; Inflammation; Insulin Resistance; JNK Mitogen-Activated Protein Kinases; Leptin; Liver Neoplasms; Metformin; Non-alcoholic Fatty Liver Disease; Obesity; Risk Factors; S-Adenosylmethionine; Toll-Like Receptors

2015

Other Studies

4 other study(ies) available for metformin and s-adenosylmethionine

ArticleYear
Lowering homocysteine levels may prevent cardiovascular impairments? Possible therapeutic behaviors.
    Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis, 2012, Volume: 23, Issue:8

    Topics: Acetylcysteine; Aspirin; Blood Vessels; Cardiovascular Diseases; Clopidogrel; Diuretics; Fatty Acids, Omega-3; Folic Acid; Homocysteine; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypoglycemic Agents; Metformin; Platelet Aggregation Inhibitors; S-Adenosylmethionine; Ticlopidine; Vitamin B 12; Vitamin B 6

2012
Metformin regulates global DNA methylation via mitochondrial one-carbon metabolism.
    Oncogene, 2018, 02-15, Volume: 37, Issue:7

    Topics: AMP-Activated Protein Kinases; Animals; Biomarkers, Tumor; Breast Neoplasms; Carbon; Colonic Neoplasms; DNA Methylation; Electron Transport Complex I; Female; Follow-Up Studies; Gene Expression Regulation, Neoplastic; Genome, Human; Humans; Hypoglycemic Agents; Metformin; Mice; Mitochondria; S-Adenosylhomocysteine; S-Adenosylmethionine; Tumor Cells, Cultured

2018
Cholecalciferol and metformin protect against lipopolysaccharide-induced endothelial dysfunction and senescence by modulating sirtuin-1 and protein arginine methyltransferase-1.
    European journal of pharmacology, 2021, Dec-05, Volume: 912

    Topics: Antioxidants; Arginine; Cell Cycle Checkpoints; Cell Line; Cellular Senescence; Cholecalciferol; Endothelium; Homocysteine; Humans; Lipopolysaccharides; Metformin; Methylation; NAD; Nitric Oxide; Protective Agents; Protein-Arginine N-Methyltransferases; Repressor Proteins; S-Adenosylmethionine; Sirtuin 1; Telomerase; Vitamin D Response Element

2021
Metformin induces S-adenosylmethionine restriction to extend the Caenorhabditis elegans healthspan through H3K4me3 modifiers.
    Aging cell, 2022, Volume: 21, Issue:3

    Topics: Animals; Caenorhabditis elegans; Caenorhabditis elegans Proteins; Diabetes Mellitus, Type 2; Histones; Longevity; Metformin; S-Adenosylmethionine

2022